EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management

Samer Wahood iD, Omar Alani, Iyla Draw, Lara Shqair, David Wang iD, Christopher G Bunick iD, Giovanni Damiani iD, Jonathan D Ho, Sabine Obagi, Hossein Akbarialiabad, Fabrizio Galimberti, Mahmoud Ghannoum und 1 weitere

Pharmaceuticals · 26.05.2025 · 18 (6) · 800

DOI: 10.3390/ph18060800 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pharmaceuticals, online erschienen am 26.05.2025. Verfasst von Samer Wahood und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 112 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Fluoroquinolones, available in topical and oral formulations, are used to manage bacterial skin and soft tissue infections, including Pseudomonas aeruginosa, atypical mycobacteria, and select multidrug-resistant Gram-negative organisms. Their excellent tissue penetration, bactericidal activity, and convenient dosing make them effective for certain skin and soft tissue infections. However, their use is limited by potential safety concerns, including tendinopathy (odds ratio up to 9.1 in corticosteroid users), QT interval prolongation with risk of torsades de pointes, phototoxicity, and rising antimicrobial resistance.

Methods

A literature search of PubMed, Scopus, and Web of Science was conducted for articles from January 1985 to April 2025 with the search terms (quinolone OR fluoroquinolone) AND (dermatology OR “skin and soft tissue infection” OR “skin structure infection”). Abstracts and presentations were excluded. A Google search used the same terms for articles from government regulatory agencies.

Results

This review provides practical guidance on the clinical use of topical and oral fluoroquinolones in dermatology. Delafloxacin demonstrated over 90% cure rates in trials for complicated skin infections. However, serious safety concerns remain, including a ninefold increase in tendinopathy risk among older adults on corticosteroids and corrected QT intervals exceeding 500 milliseconds in high-risk patients. Phototoxicity varies, with agents like sparfloxacin linked to heightened ultraviolet sensitivity. Resistance to ciprofloxacin exceeds 20 percent in Escherichia coli and P. aeruginosa in some populations. Culture-based prescribing, shorter treatment courses, and preference for topical treatments can reduce risk and preserve efficacy.

Conclusions

Fluoroquinolones remain clinically useful in dermatology when prescribed selectively. Their appropriate use requires careful attention to patient risk factors along with their evolving resistance patterns and ongoing stewardship efforts.

Schlagwörter

Stichwörter der Autor:innen

antibiotic stewardshipbacteriadermatologyfluoroquinolonerisk managementsafetyskinskin and soft tissue infectionstendinopathytoxicity

Autor:innen und Institutionen

  • The Warren Alpert Medical School of Brown University, Providence, RI 02903, USA.
  • Department of Dermatology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
  • Department of Dermatology, University of Louisville School of Medicine, Louisville, KY 40202, USA.
  • Chobanian & Avedisian School of Medicine, Boston University, Boston, MA 02118, USA.
  • Department of Dermatology and Program in Translational Biomedicine, Yale School of Medicine, New Haven, CT 06520, USA.
  • Department of Dermatology, University of Milan, 20122 Milan, Italy.

ORCID-Profile: Samer Wahood, David Wang, Christopher G Bunick, Giovanni Damiani, Ayman Grada

Zitieren

APA

Wahood, S., Alani, O., Draw, I., Shqair, L., Wang, D., Bunick, C. G., Damiani, G., Ho, J. D., Obagi, S., Akbarialiabad, H., Galimberti, F., Ghannoum, M., & Grada, A. (2025). Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management. Pharmaceuticals, 18(6), 800. https://doi.org/10.3390/ph18060800

Vancouver

Wahood S, Alani O, Draw I, Shqair L, Wang D, Bunick CG, et al. Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management. Pharmaceuticals. 2025;18(6):800. doi:10.3390/ph18060800

BibTeX
@article{Wahood2025,
  author = {Wahood, Samer and Alani, Omar and Draw, Iyla and Shqair, Lara and Wang, David and Bunick, Christopher G and Damiani, Giovanni and Ho, Jonathan D and Obagi, Sabine and Akbarialiabad, Hossein and Galimberti, Fabrizio and Ghannoum, Mahmoud and Grada, Ayman},
  title = {Fluoroquinolones for Dermatologists: A Practical Guide to Clinical Use and Risk Management},
  journal = {Pharmaceuticals},
  year = {2025},
  volume = {18},
  number = {6},
  pages = {800},
  doi = {10.3390/ph18060800}
}
Kostenlos starten →